Motorola Solutions, Inc. R&D decreased by 6.7% to $252.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 8.2%, from $233.00M to $252.00M. Over 4 years (FY 2021 to FY 2025), R&D shows an upward trend with a 7.3% CAGR.
Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.
Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...
Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.
research_and_development| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $181.00M | $183.00M | $189.00M | $188.00M | $191.00M | $197.00M | $202.00M | $210.00M | $215.00M | $215.00M | $218.00M | $218.00M | $220.00M | $234.00M | $246.00M | $233.00M | $231.00M | $237.00M | $270.00M | $252.00M |
| QoQ Change | — | +1.1% | +3.3% | -0.5% | +1.6% | +3.1% | +2.5% | +4.0% | +2.4% | +0.0% | +1.4% | +0.0% | +0.9% | +6.4% | +5.1% | -5.3% | -0.9% | +2.6% | +13.9% | -6.7% |
| YoY Change | — | — | — | — | +5.5% | +7.7% | +6.9% | +11.7% | +12.6% | +9.1% | +7.9% | +3.8% | +2.3% | +8.8% | +12.8% | +6.9% | +5.0% | +1.3% | +9.8% | +8.2% |
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Products and Systems Integration | $142.00M | $143.00M | $146.00M | $168.00M | $152.00M |
| Software and Services | $91.00M | — | — | — | — |
| Total | $233.00M | $231.00M | $237.00M | $270.00M | $252.00M |